Priority 2 from the Multiple Sclerosis PSP
| UNCERTAINTY: How can multiple sclerosis be prevented? (JLA PSP Priority 2) | |
|---|---|
| Overall ranking | 2 |
| JLA question ID | 0016/2 |
| Explanatory note | No relevant systematic reviews identified |
| Evidence |
No evidence found |
| Systematic reviews that need extending or updating |
No reviews found |
| Systematic reviews in preparation |
No reviews found |
| Ongoing controlled trials |
Efficacy of cholecalciferol (Vitamin D3) for delaying the diagnosis of MS after a clinically isolated syndrome D-Lay-MS NCT01817166 Dose-related effects of Vitamin D3 on immune responses in patients with clinically isolated syndrome CISAVID NCT01728922 |
| Health Research Classification System category | Neurological |
| Extra information provided by this PSP | |
|---|---|
| Original uncertainty examples | No examples provided. This is an indicative uncertainty and several submissions were merged to form this one. |
| Submitted by | 16 patients ~ 8 carers ~ 7 clinicians |
| Outcomes to be measured | Incidence of multiple sclerosis; adverse effects or complications; acceptability to patients or carers; health related quality of life; and costs |
| PSP information | |
|---|---|
| PSP unique ID | 0016 |
| PSP name | Multiple Sclerosis |
| Total number of uncertainties identified by this PSP. | 82 (To see a full list of all uncertainties identified, please see the detailed spreadsheet held on the JLA website) |
| Date of priority setting workshop | July 2013 |